Do you own the FTSE 100’s best performing stocks?

Edward Sheldon looks at the top performing FTSE 100 stocks. Does your portfolio contain these companies?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I look at the top performing FTSE 100 stocks from a one, three and five year perspective.  There’s no doubt the results throw up a few surprises.  Does your portfolio contain any of these stocks?

One year top performers

Over the last 12 months, the best performing stocks have been Fresnillo (+95%), Randgold Resources Limited (+66%), Paddy Power Betfair (+60%), Admiral Group (+46%) and Mediclinic International (+43%).

This is certainly a diverse selection of stocks and there’s every chance that investors who own a portfolio of ‘mainstream’ popular stocks might not own any of these stocks.

Fresnillo and Randgold Resources produce silver and gold, respectively, and their share prices have clearly been boosted by the market uncertainty over the last year. Indeed, on the back of the EU referendum result on Friday, Randgold spiked 28% higher, while Fresnillo jumped 12%.

Paddy Power Betfair has steamed ahead after the merger, while Admiral Group has enjoyed strong momentum after lifting its dividend by 16% for FY2015.

Mediclinic International has likely gone under the radar for many investors since joining the FTSE 100 in March. But with revenues forecast to power ahead over the next two years, it’s no surprise this stock is on the top performer’s list.

Three year stars

On a three year view, the best performing stocks on an annualised basis have been Hikma Pharmaceuticals (+37%pa) , DCC (+37%pa), Mediclinic International (+35%pa), London Stock Exchange Group (+30%pa) and Shire (+28%pa).

Once again, several of these stocks are not mainstream ones. Furthermore, many have been promoted into the FTSE 100 quite recently, which illustrates the importance of looking outside the FTSE 100 when looking for growth opportunities.

Headquartered in Jordan, Hikma joined the FTSE 100 for the first time last year, before being demoted from the index in March and then re-entering the index earlier this month. The company has an excellent record of generating strong shareholder returns and could certainly provide an alternative to the larger slow-burning healthcare stocks such as GlaxoSmithKline.

International sales, marketing, distribution and business support services group DCC has seen strong earnings growth in the last few years and the company’s promotion to the FTSE 100 in December last year has clearly generated extra interest in the stock.

London Stock Exchange Group jumped after acquisition interest from Deutsche Bourse earlier this year, although this merger may clearly face challenges after the recent Brexit vote.

Shire makes the ‘three year best performing’ list despite the company’s share price falling from over 5,700p in August last year to 4,100p today.

Five years champions

Lastly, over a five year period, the top performing stocks on an annualised basis are Ashtead Group (+47%pa), Barratt Developments (+34%pa), easyJet (+34%pa), Taylor Wimpey (+34%) and Persimmon (+33%pa).

There’s a clear theme here, with property development stocks taking three of the top five positions, even after all three companies were hit heavily on Friday after the EU referendum result.

International equipment rental group Ashtead claims the top spot after enjoying fantastic growth in earnings over the last five years, although it was starting from a low base after the Global Financial Crisis.

EasyJet joins makes the top five after seeing earnings rise dramatically in the last five years.  

Edward Sheldon owns shares in GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

2 top growth stocks to consider for an ISA in April

The UK market is home to some fantastic under-the-radar growth stocks trading at very reasonable valuations. Here are two of…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Could thinking like Warren Buffett help create a market-beating ISA?

Christopher Ruane zooms in on some aspects of Warren Buffett's investing approach he thinks could help an ambitious ISA investor…

Read more »

British pound data
Investing Articles

£10,000 invested in a FTSE 100 index tracker at the start of March is now worth…

Anyone who invested money in a FTSE 100 index tracker at the start of the month may wish to look…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Should investors consider Rolls-Royce shares as war rocks global markets?

Investors who thought Rolls-Royce shares had grown too expensive might have second thoughts as Iran turmoil rattles the FTSE 100,…

Read more »

Young black woman walking in Central London for shopping
Investing Articles

Some lucky ISA investors could pick up £2,000 for free in the next month. Here’s how

The UK government is handing out free money to some ISA investors to help them save for retirement. Here’s a…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Is this the best time to buy dividend shares since Covid-19?

A volatile stock market gives investors a chance to buy shares with unusually high dividend yields. Stephen Wright highlights one…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Are we staring at a once-in-a-decade chance to buy this beaten-down UK growth stock?

Investors couldn't get enough of this FTSE 100 growth stock, but the last 10 years have been pretty frustrating. Could…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

What I look for when searching for shares to buy

There’s a lot that goes into finding shares to buy. Ultimately though, it comes down to two things: numbers that…

Read more »